The Global COVID-19 Vaccine Delivery Devices Market size is anticipated to reach US$ 8,609 Million by 2030 with a CAGR of 7.3% from 2022 to 2030.

Global equitable access to a COVID-19 vaccine, especially for health workers and other vulnerable populations is the only way to reduce the pandemic's public health and economic impact. More than 11 billion vaccine doses had been administered worldwide by the beginning of May 2022, and now, with a reliable supply of COVID-19 vaccines, more should be done to get them to those in need. Recognizing the importance of converting vaccine doses into vaccinated, protected communities, the Vaccine Alliance launched the COVID-19 Vaccine Delivery Partnership in collaboration with UNICEF, WHO, and Gavi (CoVDP). The CoVDP builds on previous resources to support the AMC 92, with a primary focus on the 34 countries that had less than 10% coverage in January 2022. Working closely with countries to identify vaccination bottlenecks, the CoVDP provides access to immediate operational funding, technical assistance, and political engagement to quickly scale up vaccination and track progress toward targets. As a result, the demand for COVID-19 vaccine delivery devices skyrocketed from last year and is expected to continue its trend in the coming years.

COVID-19 Vaccine Delivery Devices Market Dynamics

COVID-confirmed with millions of cases and hundreds of thousands killed from the disease, the social, healthcare, and financial repercussions are likely to last for years. While drug treatments that reduce the severity of the disease may emerge, vaccination is the most effective way to control the virus in both developed and developing countries. Several technologies are being used to find an effective and safe vaccine.

In the case of COVID-19, the majority of vaccines in development target the professed spike protein. This protein is expressed on the virus's surface and enables the virus to bind to the ACE2 receptor on the cell surface, resulting in virus fusion and uptake, accompanied by the chain of events leading to virus replication.

The Richard King Mellon Foundation has awarded a grant to researchers at the University of Pittsburgh's School of Medicine and the Carnegie Mellon University's College of Engineering to create and test a novel micro-needle array platform competent of delivering vaccines directly into the skin, with the specific goal of improving COVID-19 vaccination in the developing world.

Market Insights

Devices, route of administration, and region are the three categories of the global COVID-19 vaccine delivery devices industry. Based on the devices sector, the segmentation includes syringes, jet injectors, and others. According to our research, the syringes segment will dominate the COVID-19 vaccine delivery devices market in the coming years.

The route of administration segment is further categorized into intradermal vaccination, intramuscular vaccination, and subcutaneous vaccination. Among them, intramuscular segment achieved a significant amount of market share in 2021.

Global COVID-19 Vaccine Delivery Devices Market Geographical Competition

The global COVID-19 vaccine delivery devices industry is divided into North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa. In the global COVID-19 vaccine delivery devices market, North America is expected to hold the largest market share. The market has expanded as a result of well-established healthcare infrastructure and high public awareness of vaccines. Increased R&D expenditure for new vaccine advancements are also helping to drive market growth. In contrast, the Asia-Pacific region is anticipated to witness the fastest growing. The region's improving infrastructure, as well as a huge patient pool and rising unmet vaccine needs, have all contributed to the expansion.

Global COVID-19 Vaccine Delivery Devices Industry Segment Analysis

COVID-19 Vaccine Delivery Devices Market By Devices

·         Syringes

·         Jet Injectors

·         Others

COVID-19 Vaccine Delivery Devices Market By Route of Administration

·         Intramuscular Vaccination

·         Intradermal Vaccination

·         Subcutaneous Vaccination

·         Other Vaccinations

COVID-19 Vaccine Delivery Devices Market Leading Companies

This section of the study honors the market's top vendors 3M, Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.),Becton Dickinson & Company, Corium International, Inc., Gerresheimer AG, PharmaJet, SCHOTT AG, and Vaxxas are the key companies mentioned in the research.

COVID-19 Vaccine Delivery Devices Market Regions